Emergent Biosolutions Inc (EBS)
Total Liabilities
$775.40M
Quarterly · Period ending: · USD
EBS Total Liabilities
Latest reported$775.40Mperiod ending
Latest reported$775.40Mperiod ending
EBS Quarterly Total Liabilities ($1.78B → $775.40M)
Quarterly total liabilities
High-resolution chart · PNG
EBS total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 775,400,000 | |
| 797,300,000 | |
| 796,000,000 | |
| 878,500,000 | |
| 880,900,000 | |
| 873,400,000 | |
| 914,100,000 | |
| 969,400,000 | |
| 1,127,200,000 | |
| 1,139,700,000 | |
| 1,185,600,000 | |
| 1,195,900,000 | |
| 1,222,500,000 | |
| 1,747,200,000 | |
| 1,778,600,000 | |
| 1,459,200,000 | |
| 1,222,200,000 | |
| 1,205,100,000 | |
| 1,346,200,000 | |
| 1,344,800,000 | |
| 1,371,500,000 | |
| 1,377,300,000 | |
| 1,436,200,000 | |
| 1,364,800,000 | |
| 1,267,300,000 | |
| 1,203,900,000 | |
| 1,238,800,000 | |
| 1,298,800,000 | |
| 1,332,400,000 | |
| 1,166,000,000 | |
| 1,218,500,000 | |
| 206,974,000 | |
| 200,545,000 | |
| 187,187,000 | |
| 157,861,000 | |
| 360,492,000 | |
| 349,884,000 | |
| 341,220,000 | |
| 373,906,000 | |
| 384,403,000 | |
| 383,794,000 | |
| 368,915,000 | |
| 383,575,000 | |
| 371,236,000 | |
| 381,072,000 | |
| 379,967,000 | |
| 392,061,000 | |
| 356,153,000 | |
| 349,482,000 | |
| 345,756,000 | |
| 137,465,000 | |
| 128,607,000 | |
| 106,532,000 | |
| 102,580,000 | |
| 122,102,000 | |
| 111,613,000 | |
| 104,618,000 | |
| 102,592,000 | |
| 130,137,000 | |
| 128,459,000 | |
| 112,754,000 | |
| 112,354,000 | |
| 126,758,000 | |
| 87,243,000 | |
| 83,704,000 | |
| 93,675,000 | |
| 100,874,000 | |
| 79,420,000 | |
| 95,983,000 | |
| 91,001,000 | |
| 91,439,000 | |
| 94,567,000 | |
| 96,804,000 | |
| 95,044,000 | |
| 102,349,000 | |
| 83,258,000 | |
| 66,976,000 | |
| 65,872,000 | |
| 99,783,000 | |
| 74,072,000 | |
| 40,595,000 | |
| 46,107,000 | |
| 1,340,000,000 | |
| 1,783,600,000 |